These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20637220)

  • 21. Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins.
    Lam KH; Tremblay JM; Vazquez-Cintron E; Perry K; Ondeck C; Webb RP; McNutt PM; Shoemaker CB; Jin R
    Cell Rep; 2020 Feb; 30(8):2526-2539.e6. PubMed ID: 32101733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.
    Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M
    J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.
    Jiang Y; Wang R; Guo J; Cheng K; Chen L; Wang X; Li Y; Du P; Gao C; Lu J; Yu Y; Yang Z
    Front Immunol; 2024; 15():1380694. PubMed ID: 38779676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.
    Baghban R; Gargari SL; Rajabibazl M; Nazarian S; Bakherad H
    Biotechnol Appl Biochem; 2016; 63(2):200-5. PubMed ID: 24673401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the functional activity of botulinum neurotoxin subtype B6.
    Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
    Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice.
    Godakova SA; Noskov AN; Vinogradova ID; Ugriumova GA; Solovyev AI; Esmagambetov IB; Tukhvatulin AI; Logunov DY; Naroditsky BS; Shcheblyakov DV; Gintsburg AL
    Toxins (Basel); 2019 Aug; 11(8):. PubMed ID: 31394847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.
    Nakamura K; Kohda T; Seto Y; Mukamoto M; Kozaki S
    Vet Microbiol; 2013 Mar; 162(2-4):881-890. PubMed ID: 23206412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA.
    Fan Y; Barash JR; Conrad F; Lou J; Tam C; Cheng LW; Arnon SS; Marks JD
    Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
    Tsukamoto K; Kohda T; Mukamoto M; Takeuchi K; Ihara H; Saito M; Kozaki S
    J Biol Chem; 2005 Oct; 280(42):35164-71. PubMed ID: 16115873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.
    Nuemket N; Tanaka Y; Tsukamoto K; Tsuji T; Nakamura K; Kozaki S; Yao M; Tanaka I
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May; 66(Pt 5):608-10. PubMed ID: 20445271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.
    Kalb SR; Santana WI; Geren IN; Garcia-Rodriguez C; Lou J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
    BMC Biochem; 2011 Nov; 12():58. PubMed ID: 22085466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reengineering the specificity of the highly selective Clostridium botulinum protease via directed evolution.
    Dyer RP; Isoda HM; Salcedo GS; Speciale G; Fletcher MH; Le LQ; Liu Y; Brami-Cherrier K; Malik SZ; Vazquez-Cintron EJ; Chu AC; Rupp DC; Jacky BPS; Nguyen TTM; Katz BB; Steward LE; Majumdar S; Brideau-Andersen AD; Weiss GA
    Sci Rep; 2022 Jun; 12(1):9956. PubMed ID: 35705606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.
    Conway JO; Sherwood LJ; Collazo MT; Garza JA; Hayhurst A
    PLoS One; 2010 Jan; 5(1):e8818. PubMed ID: 20098614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
    Bakherad H; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Mohammadi M; Ebrahimizadeh W; Safaee Ardakani L; Zare H
    Mol Biotechnol; 2013 Oct; 55(2):159-67. PubMed ID: 23666874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative immunochemical characteristics of botulinum neurotoxin type A and its associated proteins.
    Bryant AM; Cai S; Singh BR
    Toxicon; 2013 Sep; 72():126-32. PubMed ID: 23811077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B; Colliou N; Zadeh M; Ge Y; Gong M; Owen JL; Valletti M; Jobin C; Mohamadzadeh M
    Vaccine; 2018 Jan; 36(1):155-164. PubMed ID: 29180028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F.
    Schmidt JJ; Stafford RG; Millard CB
    Anal Biochem; 2001 Sep; 296(1):130-7. PubMed ID: 11520041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.